These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8729410

  • 1. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P, Pouteau M, Martinot M, Boyer N, Castelnau C, Benhamou JP, Erlinger S.
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract] [Full Text] [Related]

  • 2. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M, Block G, Finkelstein SD.
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [Abstract] [Full Text] [Related]

  • 3. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS.
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract] [Full Text] [Related]

  • 4. Therapy of hepatitis C: alpha interferon and ribavirin.
    Reichard O, Schvarcz R, Weiland O.
    Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
    [Abstract] [Full Text] [Related]

  • 5. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T, Seelig R, Dette S, Bühring HJ, Renz M, Kwon S, Wiedmann KH, Weber P.
    Hepatogastroenterology; 1997 Sep; 44(14):484-91. PubMed ID: 9164523
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E, Wawrzynowicz-Syczewska M, Jurczyk K, Morańska I, Urbanowicz W, Boroń-Kaczmarska A.
    Wiad Lek; 2005 Sep; 58(11-12):616-21. PubMed ID: 16594470
    [Abstract] [Full Text] [Related]

  • 7. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G, Fazio V, Tantimonaco G.
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [Abstract] [Full Text] [Related]

  • 8. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN, Jen CM, Young KC, Chen CY, Lu SN, Wang CS, Chang TT.
    Hepatogastroenterology; 2003 Dec; 50(50):449-52. PubMed ID: 12749244
    [Abstract] [Full Text] [Related]

  • 9. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V, Harzic M, Doll J, Dubeaux B, Ghnassia JC, Andrieu J.
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [Abstract] [Full Text] [Related]

  • 10. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A, Yong JF, Zulkifli HI, Jamal R.
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of viral hepatitis C: what are the perspectives?].
    Giostra E, Malè PJ.
    Rev Med Suisse Romande; 1994 Sep; 114(9):759-64. PubMed ID: 7939106
    [No Abstract] [Full Text] [Related]

  • 13. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 14. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M, Ciuffreda D, Moradpour D, Pascual M.
    Transplantation; 2007 Feb 27; 83(4):525-6. PubMed ID: 17318091
    [No Abstract] [Full Text] [Related]

  • 15. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC, Roffi L, Antonelli G, Bellati G, Pacchetti S, Di Nolfo MA, Panizzuti F, Moretti G, Piperno A, Pozzi M.
    Prog Clin Biol Res; 1993 Feb 27; 382():359-64. PubMed ID: 8502704
    [No Abstract] [Full Text] [Related]

  • 16. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S, Foli M, Di Tomaso M, Gramantieri L, Masci C, Bolondi L.
    Ital J Gastroenterol Hepatol; 1999 Mar 27; 31(2):130-4. PubMed ID: 10363198
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic viral hepatitis].
    Marcellin P, Metreau JM, Pol S, Zoulim F.
    Ann Gastroenterol Hepatol (Paris); 1996 Mar 27; 32(2):85-7. PubMed ID: 8737503
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK.
    Hepatology; 1998 Jul 27; 28(1):245-52. PubMed ID: 9657119
    [Abstract] [Full Text] [Related]

  • 19. Treatment of patients with hepatitis C virus on the waiting list.
    Everson GT.
    Liver Transpl; 2003 Nov 27; 9(11):S90-4. PubMed ID: 14586902
    [Abstract] [Full Text] [Related]

  • 20. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.
    Transplant Proc; 2004 Nov 27; 36(6):1831-4. PubMed ID: 15350490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.